KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to -$679000.0.

  • Biolife Solutions' Change in Account Payables fell 8203.75% to -$679000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $31000.0, marking a year-over-year increase of 10050.13%. This contributed to the annual value of $26000.0 for FY2024, which is 10030.86% up from last year.
  • Biolife Solutions' Change in Account Payables amounted to -$679000.0 in Q3 2025, which was down 8203.75% from $373000.0 recorded in Q2 2025.
  • Biolife Solutions' 5-year Change in Account Payables high stood at $4.2 million for Q3 2021, and its period low was -$5.0 million during Q4 2023.
  • In the last 5 years, Biolife Solutions' Change in Account Payables had a median value of -$171000.0 in 2022 and averaged -$373736.8.
  • Per our database at Business Quant, Biolife Solutions' Change in Account Payables soared by 72338.83% in 2021 and then crashed by 272923.98% in 2023.
  • Over the past 5 years, Biolife Solutions' Change in Account Payables (Quarter) stood at $650000.0 in 2021, then surged by 519.85% to $4.0 million in 2022, then tumbled by 225.22% to -$5.0 million in 2023, then soared by 123.09% to $1.2 million in 2024, then tumbled by 158.28% to -$679000.0 in 2025.
  • Its Change in Account Payables was -$679000.0 in Q3 2025, compared to $373000.0 in Q2 2025 and -$828000.0 in Q1 2025.